The Milner Therapeutics Institute has joined a three-year collaboration with the science funding agency ARIA and multiple Cambridge partners.

Symbiosis Pharmaceutical Services Ltd announces the purchase of new premises in Stirling, Scotland, UK. The additional space will double the total footprint of the company across the four facilities that it will operate from, increasing manufacturing capacity by 50% in the short-term.

PIR International recently partnered with CHARM Therapeutics and is pleased to announce the appointment of Beverley Carr as Chief Business Officer.

In this insightful blog, Louis Taylor, CEO of the British Business Bank, explores how the Mansion House reforms and increased pension fund investments could unlock billions in domestic capital, fueling the next generation of UK innovators.

The government's plan to put life sciences up in lights this Sunday ahead of the International investment Summit was somewhat overtaken by the news of the reorganisation of Keir Starmer's Number 10 team which dominated headlines. Nevertheless, it's been a busy week of announcements affecting our sector.

The BIA’s policy and public affairs team attended the conferences of the three major UK parties this year. This is a key point in the political calendar and allows us to highlight the sector through fringe events, meet policymakers, and get a sense of the political environment.